The federal government is bracing for new tariffs on one of Australia's largest exports to the United States, with President Donald Trump threatening to hit pharmaceuticals with tariffs as high as 250 percent. But the drug industry's peak body says the sector is facing a far more urgent problem, warning people could die while waiting for lifesaving medicines to be listed on the pharmaceutical benefits scheme.
